Tecovirimat Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 1 pharmaceutical company such as SIGA TECHNOLOGIES. It is marketed under 1 brand name, including TPOXX. Available in 2 different strengths, such as 200MG, 200MG/20ML (10MG/ML), and administered through 2 routes including CAPSULE;ORAL, SOLUTION;INTRAVENOUS.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 1 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...

watch_later Watch: autorenew Loading watch analysis...

rocket_launch Opportunity: autorenew Loading opportunity analysis...

Country

flag

Legal Status

gavel

Expiry From

calendar_today

Expiry To

calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines

✓ Full patent family details and status updates

Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines

✓ Full patent family details and status updates

✓ Latest exclusivity data and extensions

Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines

✓ Full patent family details and status updates

Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength	Route of Administration	Companies	Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

	Patent Number	Publication Date	Legal Status	Patent Expiry Date
{"application_id":"51618","ingredient":"TECOVIRIMAT","trade_name":"TPOXX","family_id":"8f0b5471d83e4870be7b","publication_number":"US8039504B2","cleaned_patent_number":"8039504","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-07-23","publication_date":"2011-10-18","legal_status":"Granted"}	US8039504B2 Formulation	18 Oct, 2011	Granted	23 Jul, 2027
{"application_id":"51627","ingredient":"TECOVIRIMAT","trade_name":"TPOXX","family_id":"c773713db52e48d6b8a7","publication_number":"US9339466B2","cleaned_patent_number":"9339466","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-03-23","publication_date":"2016-05-17","legal_status":"Granted"}	US9339466B2 Molecular Formulation	17 May, 2016	Granted	23 Mar, 2031
{"application_id":"75130","ingredient":"TECOVIRIMAT","trade_name":"TPOXX","family_id":"051bbf8e4e1a43158b37","publication_number":"US10576165B2","cleaned_patent_number":"10576165","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-08-02","publication_date":"2020-03-03","legal_status":"Granted"}	US10576165B2 Formulation	03 Mar, 2020	Granted	02 Aug, 2031
{"application_id":"75147","ingredient":"TECOVIRIMAT","trade_name":"TPOXX","family_id":"051bbf8e4e1a43158b37","publication_number":"US9233097B2","cleaned_patent_number":"9233097","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-08-02","publication_date":"2016-01-12","legal_status":"Granted"}	US9233097B2 Formulation	12 Jan, 2016	Granted	02 Aug, 2031
{"application_id":"75148","ingredient":"TECOVIRIMAT","trade_name":"TPOXX","family_id":"051bbf8e4e1a43158b37","publication_number":"US9907859B2","cleaned_patent_number":"9907859","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-08-02","publication_date":"2018-03-06","legal_status":"Granted"}	US9907859B2	06 Mar, 2018	Granted	02 Aug, 2031
{"application_id":"51589","ingredient":"TECOVIRIMAT","trade_name":"TPOXX","family_id":"8f0b5471d83e4870be7b","publication_number":"US7737168B2","cleaned_patent_number":"7737168","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-09-04","publication_date":"2010-06-15","legal_status":"Granted"}	US7737168B2	15 Jun, 2010	Granted	04 Sep, 2031
{"application_id":"51666","ingredient":"TECOVIRIMAT","trade_name":"TPOXX","family_id":"c773713db52e48d6b8a7","publication_number":"US11890270B2","cleaned_patent_number":"11890270","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-08-08","publication_date":"2024-02-06","legal_status":"Granted"}	US11890270B2	06 Feb, 2024	Granted	08 Aug, 2032

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID	Title	Status	Phase	Conditions	Start Date	Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

Filter by Country

View Complete Supplier List

Unlock access to all suppliers of Tecovirimat

✓ Access a comprehensive list of global suppliers

✓ Get information on each supplier

Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.